The Lassa Fever Treatment Market was valued at USD 657.01 billion in 2025 and is projected to reach USD 1338.23 billion by 2033, growing at a CAGR of 9.30% from 2026 to 2033. The Lassa Fever Treatment Market is experiencing steady growth driven by increasing incidence of Lassa fever outbreaks across West Africa, rising global health security concerns, and expanding investment in antiviral drug research and vaccine development. Strengthening surveillance systems and international funding support from public health organizations are further accelerating market development.
3 Views
